Tolterodine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Tolterodine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking buprenorphine (a pain or opioid-treatment medicine) together with tolterodine (Detrol, used for an overactive bladder). Both can slow down the gut and both can make it harder to empty your bladder. Put together, they may raise the chance of severe constipation or trouble urinating, and in rare cases the gut can slow down so much it stops moving (called paralytic ileus).
Both drugs can also gently affect your heart's rhythm (the QT interval). This concern is mostly theoretical, meaning it's based on how the drugs work rather than lots of real cases. The good news is your care team can manage this by watching you closely, so keep taking both as prescribed and let them know about any belly or bladder changes.
Effect: Additive risk of reduced GI motility (constipation, urinary retention, potentially paralytic ileus) plus additive QT prolongation.
Mechanism: Buprenorphine's opioid effect on gut motility combines with tolterodine's antimuscarinic (anticholinergic) activity; both agents carry independent QT-prolonging potential. Pharmacodynamic, not a prodrug or PK issue.
Evidence: Theoretical; magnitude and onset not established.
- Monitor for urinary retention, constipation, and signs of ileus.
- Assess QT risk factors: hypokalemia, hypomagnesemia, bradycardia, CHF, baseline/congenital QT prolongation, digoxin therapy, recent AF cardioversion.
- Consider ECG/electrolyte monitoring in at-risk patients; the label advises avoiding buprenorphine with QT-prolonging drugs.
What happens
An increased risk of paralytic ileus and an increased risk of QT interval prolongation
Interaction Deep Dive
Do not use buprenorphine together with medications capable of prolonging the QT interval2. When buprenorphine is given alongside an anticholinergic agent, the combination can lead to urinary retention or severe constipation, potentially progressing to paralytic ileus. For that reason, watch patients for indications of urinary retention or diminished gastric motility during concurrent use of buprenorphine and anticholinergic drugs. It remains unknown what risk results from pairing buprenorphine with additional QT prolonging agents. Take these points into account when making clinical decisions about prescribing buprenorphine to patients who carry risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia 1.
Why it happens (mechanism)
Additive effects on gastric motility; additive QT interval prolongation
How to manage this interaction
This combination can usually be managed with awareness and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.
- Watch for constipation, belly bloating or pain, or trouble passing urine, and report these promptly.
- Ask your pharmacist about staying hydrated and using stool support if constipation becomes a problem.
- Tell your prescriber if you have heart rhythm issues, low potassium or magnesium, or take other medicines that affect the heart, since your team may check an ECG or bloodwork.
Your dose and monitoring can be individualized by your care team, and they may consider an alternative if problems arise.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Tolterodine and Buprenorphine together?
Using buprenorphine with tolterodine can add up to cause severe constipation, urinary retention, or (rarely) a stalled gut, plus a possible heart-rhythm effect. Keep taking both as prescribed and report belly or bladder symptoms to your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Tolterodine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Tolterodine and Buprenorphine interaction managed?
This combination can usually be managed with awareness and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Watch for constipation, belly bloating or pain, or trouble passing urine, and report these promptly. Ask your pharmacist about staying hydrated and using stool support if constipation becomes a problem. Tell your prescriber if you have h… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Tolterodine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
Keep reading about Buprenorphine
Keep reading about Tolterodine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist